Estradiol on TRT: when men need an aromatase inhibitor and most don't

If you've been on TRT and your clinic prescribed anastrozole (Arimidex) at the same time as your testosterone — without a specific reason tied to your bloodwork — you're in the majority. You're also probably on a protocol the published literature doesn't support.

Estradiol management on TRT has become one of the most over-treated parts of men's hormone therapy. The case for restraint, what the bloodwork actually shows, and when an aromatase inhibitor is genuinely needed — here's the clinical view.

Why men have estradiol in the first place.

Men naturally produce estradiol, primarily by converting testosterone via the enzyme aromatase (mostly in fat tissue, but also in bone, brain, vasculature, and the testes themselves). Healthy adult male estradiol typically runs 20–55 pg/mL on sensitive immunoassay or LC-MS/MS assays.

Estradiol isn't a "female hormone" you accidentally make. It plays an essential role in:

• Libido and erectile function — men with too-low estradiol consistently report reduced libido, often more than men with low testosterone.
• Bone density — estradiol is the primary driver of male bone mineral density, more important than testosterone itself for fracture prevention.
• Joint and connective tissue health.
• Mood and cognition — both very low and very high estradiol are associated with depressive symptoms in men.
• Lipid profile — moderate estradiol supports healthier HDL and triglycerides.

Over-suppression of estradiol — which is exactly what aromatase inhibitors do — causes most of these issues in reverse.

What happens to estradiol when you start TRT.

TRT raises testosterone. Some percentage of that testosterone aromatizes to estradiol. As a result, estradiol typically rises along with testosterone — often into the upper half of the normal range, sometimes above it.

Common patterns:

• Most men's estradiol settles in the 30–60 pg/mL range on a properly-dosed TRT protocol. This is healthy, often ideal, and doesn't warrant intervention.
• A subset see estradiol climb above 60 pg/mL. Whether this warrants treatment depends entirely on symptoms.
• A smaller subset see estradiol climb well above 80 pg/mL and develop symptoms (water retention, breast tissue tenderness, mood changes). This is the patient who may benefit from an aromatase inhibitor.

What the literature actually says.

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy is explicit: routine use of aromatase inhibitors with TRT is not recommended. The guideline specifically cautions against treating elevated estradiol numbers without symptoms.

The American Urological Association's 2018 testosterone deficiency guideline reaches the same conclusion: aromatase inhibitors should be reserved for symptomatic estradiol excess that doesn't respond to dose adjustment.

When an aromatase inhibitor is actually warranted.

The clinical case for prescribing anastrozole — typically 0.25–0.5 mg once or twice weekly — is real but narrow. Indications we'd consider it:

• Symptomatic gynecomastia (breast tissue tenderness or development that doesn't resolve with dose reduction)
• Significant fluid retention despite reasonable testosterone dosing
• Mood symptoms tied clearly to estradiol elevation (not the more common low-estradiol-from-overtreatment mood symptoms)
• Sustained estradiol above 80–100 pg/mL with concerning symptoms

Important: each of these should first prompt a check of whether the testosterone dose is simply too high. Lowering testosterone often lowers estradiol meaningfully, with no AI needed.

When men get harmed by routine AI prescriptions.

Over-suppression of estradiol — most often from twice-weekly anastrozole given prophylactically — produces a recognizable cluster:

• Loss of libido even with great testosterone numbers (this is the most common patient complaint and is often misdiagnosed as needing more testosterone)
• Erectile difficulty
• Joint pain and stiffness (especially shoulders, knees, hips)
• Depressive mood, anxiety, anhedonia
• Hot flashes
• Faster bone loss (often invisible without DEXA monitoring)

Many men presenting with these symptoms on TRT are still on prophylactic anastrozole their clinic prescribed automatically. Stopping the AI — not adjusting testosterone — often resolves the cluster in 4–8 weeks.

A note on assay quality.

Standard estradiol immunoassays (the ones in most basic blood panels) overestimate estradiol in men by 20–40% and produce unreliable readings. The accurate test is a sensitive estradiol assay (sometimes called "ultrasensitive estradiol" or LC-MS/MS estradiol). Many of the men diagnosed with "high estradiol" on TRT actually have normal estradiol misread by the wrong assay.

If your clinic is checking estradiol with the standard immunoassay and recommending an AI based on that number, ask for the sensitive assay before agreeing to start the drug.

What about other ways to manage elevated estradiol?

Before reaching for anastrozole, dose adjustments to address elevated estradiol with symptoms:

• Reduce testosterone dose. Often the simplest solution. Less substrate to aromatize.
• Switch from intramuscular to subcutaneous injection. SubQ tends to produce flatter testosterone (and estradiol) curves with less peak-trough variability.
• Split the dose into more frequent, smaller injections. Twice or three times weekly produces less variability than weekly.
• Address body composition. Aromatase activity is concentrated in adipose tissue. Lower body fat percentage = less aromatization.

All of these address the underlying physiology rather than blocking the conversion downstream.

The bottom line.

Most TRT patients do best with no aromatase inhibitor, ever. A smaller subset benefit from a low, infrequent dose for a specific period when warranted by symptoms — not bloodwork alone. The clinics still routinely prescribing anastrozole alongside every testosterone protocol are practicing an outdated standard.

If you're on TRT and you've felt worse since the addition of anastrozole, that's the conversation worth having with your clinician. Pair this with TRT vs. enclomiphene and morning testosterone testing for the full diagnostic picture.

The right testosterone protocol is the one that improves your bloodwork and your life. If you're feeling worse on TRT than off it, the medication you should suspect first isn't the testosterone.

Sources: Endocrine Society 2018 testosterone therapy clinical practice guideline; American Urological Association 2018 testosterone deficiency guideline; position statements on sensitive estradiol assay in men.

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.